“People under 60 years of age can: take a second dose of Vaxzevria [new name given to AstraZeneca], with an interval of 12 weeks after the first dose, according to the current recommendation of the European Medicines Agency (EMA ) or wait for new data to be known in relation to the use of a vaccine of another brand, to complete the vaccination schedule ”, states the DGS.

"This decision must be informed, free and clarified, after reading an information leaflet that will be available in due course", adds the document available on the official website of the institution directed by Graça Freitas.

The European agency last week made a second update on its guidelines regarding this vaccine, in which it recommended that people who had been inoculated with the first dose should complete the vaccination schedule with the second dose, since at that time there was " limited information”on the possibility of combining with another of the available vaccines.

However, the DGS is clear about the vaccination schedule for users over the age of 60, for whom it recommends taking the second dose of the vaccine developed by the pharmaceutical company AstraZeneca and the University of Oxford at an interval of 12 weeks after the first dose.